WISP1 and Macrophage Migration Inhibitory Factor in Respiratory Inflammation: Novel Insights and Therapeutic Potentials for Asthma and COPD
International Journal of Molecular Sciences · 18.09.2024 · 25 (18) · 10049
DOI: 10.3390/ijms251810049 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.09.2024. Verfasst von Maria-Elpida Christopoulou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry, Department of Chemistry, University of Patras, 26504 Patras, Greece. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, CCN Intercellular Signaling Proteins, Asthma, Macrophage Migration-Inhibitory Factors. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 302 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: COPD
Abstract (Originalsprache)
Recent advancements highlight the intricate interplay between the extracellular matrix (ECM) and immune responses, notably in respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD). The ECM, a dynamic structural framework within tissues, orches-trates a plethora of cellular processes, including immune cell behavior and tissue repair mecha-nisms. WNT1-inducible-signaling pathway protein 1 (WISP1), a key ECM regulator, controls immune cell behavior, cytokine production, and tissue repair by modulating integrins, PI3K, Akt, β-catenin, and mTOR signaling pathways. WISP1 also induces macrophage migration inhibitory factor (MIF) expression via Src kinases and epidermal growth factor receptor (EGFR) activation. MIF, through its wide range of activities, enhances inflammation and tissue restructuring. Rec-ognized for its versatile roles in regulating the immune system, MIF interacts with multiple immune components, such as the NLRP3 inflammasome, thereby sustaining inflammatory pro-cesses. The WISP1–MIF axis potentially unveils complex molecular mechanisms governing im-mune responses and inflammation. Understanding the intricate roles of WISP1 and MIF in the pathogenesis of chronic respiratory diseases such as asthma and COPD could lead to the identi-fication of novel targets for therapeutic intervention to alleviate disease severity and enhance patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biochemistry, Department of Chemistry, University of Patras, 26504 Patras, Greece.
- Clinic of Pneumology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
ORCID-Profile: Maria-Elpida Christopoulou, Spyros S Skandalis
Zitieren
APA
Christopoulou, M. E., Aletras, A. J., Papakonstantinou, E., Stolz, D., & Skandalis, S. S. (2024). WISP1 and Macrophage Migration Inhibitory Factor in Respiratory Inflammation: Novel Insights and Therapeutic Potentials for Asthma and COPD. International Journal of Molecular Sciences, 25(18), 10049. https://doi.org/10.3390/ijms251810049
Vancouver
Christopoulou ME, Aletras AJ, Papakonstantinou E, Stolz D, Skandalis SS. WISP1 and Macrophage Migration Inhibitory Factor in Respiratory Inflammation: Novel Insights and Therapeutic Potentials for Asthma and COPD. International Journal of Molecular Sciences. 2024;25(18):10049. doi:10.3390/ijms251810049
BibTeX
@article{Christopoulou2024,
author = {Christopoulou, Maria-Elpida and Aletras, Alexios J and Papakonstantinou, Eleni and Stolz, Daiana and Skandalis, Spyros S},
title = {WISP1 and Macrophage Migration Inhibitory Factor in Respiratory Inflammation: Novel Insights and Therapeutic Potentials for Asthma and COPD},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {18},
pages = {10049},
doi = {10.3390/ijms251810049}
}
EUVIMED